No Red Envelopes As MRs Granted New China Recognition
This article was originally published in PharmAsia News
The exchange of red envelopes containing gifts or money, considered customary during the Lunar New Year celebrations in China, is becoming an outdated practice as far as medical reps and physicians go, amid ever-increasing ethical scrutiny and government efforts to restore the reputation of a tarnished profession.
You may also be interested in...
Tough new rules from China’s State Council have put the country’s one million medical reps into limbo as their employers scrabble to get to grips with broad curbs on sales activities.
2016 was again another busy year on the commercial front in China, with market changes, new regulations, and ongoing pricing pressures all affecting the pharma sector. Meanwhile, the push for licensing deals, innovation, and international expansion continued apace.
As a part of real-world evidence, patient-reported outcomes can serve to evaluate a drug's efficacy against primary or secondary endpoints and also reflect safety and quality of life, notes a just-released draft regulation from China’s Center for Drug Evaluation.